AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.
AlgoTherapeutix has raised $21.5M in total funding. The most recent round was Series B. The last funding was announced in March 2023.
AlgoTherapeutix's investors include Bpifrance, Omnes Capital, Turenne Capital, UI Investissement, InnoBio Fund.
AlgoTherapeutix is headquartered in Suresnes, France.
AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.
AlgoTherapeutix is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AlgoTherapeutix — Funding & Investors." VCBacked, March 14, 2023, https://www.vcbacked.co/company/algotherapeutix. Accessed August 1, 2026.
VCBacked. (2023). AlgoTherapeutix — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/algotherapeutix
{{cite web |title=AlgoTherapeutix — Funding & Investors |url=https://www.vcbacked.co/company/algotherapeutix |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated